RE:Aphria And Tilray Mega-Merger Will Boom Or BustI dont see boooming but the $100 m inoperating savings will boost profit margins.
I sold half of my position this am, awaiting the end of taxloss selling.
I added more Hollister ( HOLL 24 cents )with the cash.
Virtually unknown, it will exit 2020 with an annual revenue runrate of $60 m CAD.
2021 will see massive expansion of its US assets, products and production capacity.
I estimate up to $300 million exit rate for 2021 and feel very comfortable with $150 m CAD
bout Alphamind Brands What is very interesting is that its Alphamind Brands is a Canada- and U.S.-based growth-stage company developing a portfolio of legal mushroom-based natural health products as well as conducting R&D initiatives, to explore psilocybin-based pharmaceutical treatments.
The company's ready-to-ship product SKUs include cordyceps, lion's mane, chaga and reishi mushroom-based liquid cordyceps, concentrated mushroom powder, tea and chocolate.
HOLL sells through 80 dispensaries in Arizona and 300 in California
The company's product SKUs under development include syrups, elixirs, cold beverages and nasal spray.
Sales begin in Q1 2021'
Looking at the very high valuations of these mushroom stocks , few of which have any sales, I see Alphamind as an excellent IPO once its sales base has been established in late 2021.